Bayer's High-Dose Eye Treatment Aflibercept Shows Positive Results in Advanced Trials
Daily NewsInvesting.com -- Bayer (ETR:BAYGN) reported positive results from late-stage trials of the high-dose eye treatment aflibercept. The drug showed improvements in vi...
Read More